Japan’s OMRON Healthcare today announced a second wave of investment in India-based Tricog Health, further deepening their collaboration to tackle the country’s cardiovascular disease (CVD) burden. 

The partnership has built the “KeeboHealth” platform  a connected health ecosystem that integrates Tricog’s AI algorithm for ECG interpretation with OMRON’s home-monitoring devices. Together, the firms are targeting remote cardiac care, faster diagnostics, better adherence to guideline-directed medical therapy (GDMT) and fewer hospital readmissions. that India faces one of the highest burdens of CVD globally, combined with a shortage of specialists and large rural populations underserved by advanced diagnostics. The strategic investment reflects a response to these structural gaps. 

Tricog’s CEO, Dr Charit Bhograj, stated
“Together, we will accelerate a hospital-to-home rollout, pairing OMRON’s world-class medical devices with Keebo™ AI-powered, guideline-aware workflows, to streamline diagnosis, improve cardiovascular management and reduce avoidable healthcare costs.” 

OMRON’s CEO Ayumu Okada added that the move supports the company’s global vision of “Going for ZERO”  zero cardiovascular events  by leveraging remote-monitoring innovation to improve outcomes at scale.

The next phases of the partnership will focus on rapid rollout of devices and analytics services, scaling in underserved regions, and establishing evidence of impact such as reductions in hospitalisations. Observers note that success will depend on patient engagement, device adoption, integration with clinician workflows and cost-effectiveness in real-world settings.